MicroRNA and cardiac pathologies.

MicroRNA and cardiac pathologies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

MicroRNA and cardiac pathologies. Abstract Text:

MicroRNA has been shown to be essential for correct cardiovascular development and physiology in a number of recent reports. Studies have also started to characterize the link between specific microRNAs and aspects of pathogenesis-such as chamber morphogenesis, conduction, and contraction-and between microRNA expression signatures and pathological cardiac phenotypes-such as hypertrophy, ischemic cardiomyopathy, dilated cardiomyopathy, and aortic stenosis. Congenital anomalies of the heart may also be associated with the dysregulation of specific microRNAs. Here we report on the latest findings.

MicroRNA and cardiac pathologies. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

MicroRNA and cardiac pathologies. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Physiological genomics

VOLUME: 34

Page Numbers: 239-42

Journal Abbreviation: Physiol. Genomics

ISSN: 1531-2267

DAY: 10

MONTH: 06

YEAR: 2008

MicroRNA and cardiac pathologies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815683

MicroRNA and cardiac pathologies. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: MicroRNA and cardiac pathologies. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for MicroRNA and cardiac pathologies.

AFFILIATION: Laboratory of Genetic and Molecular Cardiology, Science and Technology Pole, Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Physiol Genomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

MicroRNA and cardiac pathologies Related Publications

• A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells.
• Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis.
• Contrast agents and renal cell apoptosis.
• Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?
• Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?
• Efficacy of a new antihypertensive agent (indenolol) assessed by ambulatory blood pressure monitoring.
• Emerging Role of MicroRNAs in Cardiovascular Biology.
• Identification and functional expression of HCx31.9, a novel gap junction gene.
• MicroRNA and cardiac pathologies.
• MicroRNA-133 controls cardiac hypertrophy.
• MicroRNAs Control Gene Expression: Importance for Cardiac Development and Pathophysiology.
• NAD depletion by FK866 induces autophagy.
• Not Available
• On the road to the definition of the cardiac miRNome in human disease states.
• Physiological myocardial hypertrophy: how and why?
• State-of-the-Art Prevention of Heart Failure: Maladaptive versus Adaptive Hypertrophy.
• [Not Available.]
• [Not Available.]
• [Primary neuraxitis endemic in Italy of probable viral nature and its relation to viral neuraxitis of ascertained and nosographically definite etiology.]